684
Views
4
CrossRef citations to date
0
Altmetric
Research Article; Medical Biotechnology

Detection of Human parvovirus B19 (HPVB19) in serum samples from fever-rash ill individuals during the rubella outbreak (2005) in Bulgaria

, , , &
Pages 1103-1107 | Received 06 Jun 2014, Accepted 25 Jul 2014, Published online: 29 Oct 2014

References

  • Cossart YE, Field AM, Cant BR, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975;1(7898):72–73.
  • Brown KE. Variants of B19. Dev Biol (Basel). 2004;118:71–77.
  • International Committee on Taxonomy of Viruses (ICTV). Virus taxonomy: 2005 release, ICTV 8th report. Virology division, IUMS. 2005. Available from: http://www.ictvonline.org
  • Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur GG, Meritet JF, Garbarg-Chenon A. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol. 2002;76:9124–9134.
  • Young NS, Brown KE. Parvovirus B19. New England J Med. 2004;350(6):586–597.
  • Broliden K, Tolfvenstam T, Norbeck O. Clinical aspects of parvovirus B19 infection. J Intern Med. 2006;260:285–304.
  • Enders M, Schalasta G, Baisch C, Weidner A, Pukkila L, Kaikkonen L, Lankinen H, Hedman L, Soderlund-Venermo M, Hedman K. Human parvovirus B19 infection during pregnancy – value of modern molecular and serological diagnostics. J Clin Virol. 2006;35:400–406.
  • Mosquera Mdel M, de Ory F, Moreno M, Echevarria JE. Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR. J Clin Microbiol. 2002;40:111–116.
  • Nicolay N, Cotter S. Clinical and epidemiological aspects of parvovirus B19 infections in Ireland, January 1996-June 2008. EuroSurveillance. 2009;14(25):pii: 19249.
  • Lefrère JJ, Servant-Delmas A, Candotti D, Mariotti M, Thomas I, Brossard Y, Lefrere F, Girot R, Allain JP, Laperche S. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood. 2005;106:2890–2895.
  • Mihneva Z, Mihailov A, Froloshka L, Argirova RM. Seroprevalence of specific IgG antibodies to Human parvovirus B19 in immunocompromised patients. Med Rev Infect Dis. 2002;4:32–36.
  • Hübschen J, Mihneva Z, Mentis A, Schneider F, Aboudy Y, Grossman Z, Rudich H, Kasymbekova K, Sarv I, Nedeljkovic J, Tahita M, Tarnagda Z, Ouedraogo J, Gerasimova A, Moskaleva TN, Tikhonova N, Chitadze N, Forbi J, Faneye A, Otegbayo J, Charpentier E, Muller C. Phylogenetic analysis of human parvovirus B19 sequences from eleven different countries confirms the predominance of genotype 1 and suggests the spread of genotype 3b. J Clin Microbiol. 2009;47:3735–3738.
  • Cohen BJ, Gandhi JA, Clewley JP. Genetic variants of parvovirus B19 identified in the United Kingdom: implications for diagnostic testing. J Clin Virol. 2006;36:152–155.